BMJ

Listed Company · UPCOM

Price
9,600
Latest close
02 Apr 2026
P/E 10.4x
EPS (TTM) 920
ROE (TTM) 7.4%
P/B 0.7x
BVPS (Latest) 13,306
ROA (TTM) 5.5%

What Is Changing

BMJ no longer looks like a business simply rebounding from a weak base. Revenue posted +15.3% YoY, while net margin reached 15.54% with an additional +6.5pp improvement versus the prior year. The next question is whether current profit momentum can hold through the next cycle.

  • Net Margin broke above its recent high, rising 255bps to 15.54% in 2025.
  • Revenue increased 15.3% YoY to VND 616.9bn in 2025.
  • Net Income reached a multi-period high at VND 95.8bn in 2025.
Metric 2025 2024 2023 2022
Revenue 616.9 535.1 454.1 200.6
Growth +15% +18% +126%
Net Income 95.8 48.5 52.7 26.1
Net Margin 15.54% 9.07% 11.60% 12.99%

Financial Statements

Profitability

Net margin reached 15.54% while Revenue posted +15.3% YoY.

Balance Sheet

Inventory stood at 308.4bn, liabilities at 481.0bn, and equity at 1,396.6bn.

Cash Flow

Operating cash flow was -50.0bn in 2024, while investing cash flow was -87.1bn.

Financing cash flow: 126.4bn.

Item 2025 2024 2023 2022
Net Revenue
616.9 535.1 454.1 200.6
Cost of Goods Sold
485.7 457.0 372.9 163.3
Gross Profit
131.2 78.0 81.2 37.3
Financial Expenses
27.0 22.8 12.0 1.5
Selling Expenses
11.4 10.1 15.7 4.3
General and Administrative Expenses
14.4 11.8 9.8 8.0
Operating Profit
116.0 60.8 58.2 33.2
Profit Before Tax
119.4 60.7 65.8 32.9
Net Income
95.8 48.5 52.7 26.1
Profit Attributable to Parent
95.8 48.5 52.7 26.1
Earnings per Share
913.00 462.00 502.00 130.00

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.